These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 16423208)

  • 1. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
    Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M
    Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer‑mediated malignant pleural effusion.
    Du N; Li X; Li F; Zhao H; Fan Z; Ma J; Fu Y; Kang H
    Oncol Rep; 2013 Jun; 29(6):2332-40. PubMed ID: 23525453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
    Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified intrapleural cisplatin treatment for lung cancer with positive pleural lavage cytology or malignant effusion.
    Muraoka M; Oka T; Akamine S; Tagawa T; Morinaga M; Inoue M; Yamayoshi T; Hashizume S; Matsumoto K; Hayashi T; Nagayasu T
    J Surg Oncol; 2006 Mar; 93(4):323-9. PubMed ID: 16496367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapleural chemo- and hyperthermotherapies for malignant pleural effusion: a randomized prospective study.
    Chen WJ; Yuan SF; Yan QY; Xiong JP; Wang SM; Zheng WE; Zhang W; Sun HY; Chen H; Wu LL
    Cancer Invest; 2012 Feb; 30(2):126-30. PubMed ID: 22148972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515.
    Yoshida K; Sugiura T; Takifuji N; Kawahara M; Matsui K; Kudoh S; Takada M; Fukuoka M; Ariyoshi Y; Fukuda H; Saijo N
    Lung Cancer; 2007 Dec; 58(3):362-8. PubMed ID: 17716779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical observation on the efficacy of Xiaoshui decoction combined with intrapleural perfusion of cisplatin in treating malignant pleural effusion.
    SHI Z; HE QY; HUA BJ
    Chin J Integr Med; 2008 Dec; 14(4):257-61. PubMed ID: 19082796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer.
    Kasahara K; Shibata K; Shintani H; Iwasa K; Sone T; Kimura H; Nobata K; Hirose T; Yoshimi Y; Katayama N; Ishiura Y; Kita T; Nishi K; Nakatsumi Y; Ryoma Y; Fujimura M; Nakao S
    Anticancer Res; 2006; 26(2B):1495-9. PubMed ID: 16619563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of video-assisted thoracoscopic surgery vs thoracic tube drainage in synthetic therapy for malignant pleural effusion secondary to non-small cell lung cancer].
    Gu LJ; Wang WJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1023-6. PubMed ID: 16864104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intrathoracic infusion with a combination of low-dose minocycline, OK-432 and cisplatin for malignant pleural effusion].
    Ishimori S; Okada S; Yamagata S; Satoh S
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):345-9. PubMed ID: 15791817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
    J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the therapeutic effects of pleural perfusion of NDP and cDDP in NSCLC patients with malignant pleural effusion].
    Cong YY; Liu MY; Cai L
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):467-9. PubMed ID: 20819493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intrapleural bleomycin for management of malignant pleural effusions].
    Sugita T; Matsunaga K; Kobayashi H; Horikawa S; Suzuki Y; Nishiyama H; Maekawa N; Furuta H; Inui H; Fujimoto H
    Gan To Kagaku Ryoho; 1995 Aug; 22(9):1203-7. PubMed ID: 7544964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion].
    Fukuoka M; Takada M; Tamai S; Negoro S; Matsui K; Ryu S; Sakai N; Sakaguchi K
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1543-9. PubMed ID: 6206796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer.
    Tohda Y; Iwanaga T; Takada M; Yana T; Kawahara M; Negoro S; Okishio K; Kudoh S; Fukuoka M; Furuse K
    Chemotherapy; 1999; 45(3):197-204. PubMed ID: 10224342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I and pharmacokinetic study of pemetrexed plus cisplatin in chemonaive patients with locally advanced or metastatic malignant pleural mesothelioma or non-small cell lung cancer.
    Dickgreber NJ; Fink TH; Latz JE; Hossain AM; Musib LC; Thomas M
    Clin Cancer Res; 2009 Jan; 15(1):382-9. PubMed ID: 19118069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intrapericardial infusion of etoposide and cisplatin in treating malignant pericardial effusion of non-small cell lung cancer].
    Chen LK; Xu GC; Liang Y; Yang QY; Zhang LN
    Ai Zheng; 2006 Apr; 25(4):505-8. PubMed ID: 16613690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
    Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intrapleural hypotonic cisplatin treatment for carcinomatous pleuritis in cases of primary lung cancer].
    Yokouchi H; Nagase H; Ide Y; Ota H; Maruyama K; Okada K; Yanagisawa T; Mukai R; Murata K; Kinuta M; Tamai M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2124-6. PubMed ID: 20037344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.
    Rusch VW; Figlin R; Godwin D; Piantadosi S
    J Clin Oncol; 1991 Feb; 9(2):313-9. PubMed ID: 1988578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.